Advertisement
  • Remote Care

    After adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs' value for cancer patients undergoing treatment.

    by Jon Kelvey

  • July 16: The Week in Cancer News

    A study measures the global impact of alcohol on cancer incidence, and the FDA approves treatments for multiple myeloma and urothelial cancer.

    by Bradley Jones

  • Moving Away From the Maximum Tolerated Dose

    The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate.

    by Marcus A. Banks

  • July 2: The Week in Cancer News

    A study sheds light on the link between red meat consumption and colorectal cancer, and mRNA COVID-19 vaccines are effective in most cancer patients.

    by Kevin McLaughlin

  • The Individual Sphere of Influence

    Can discussion of health inequities lead to actionable change?

    by Marci A. Landsmann

  • From the Editor-in-Chief

    The Tumor Microenvironment

    Research is leading to treatments that target cancer's support system.

    by William G. Nelson, MD, PhD 

  • Forward Look

    First CAR-T Cell Therapy Approved for Multiple Myeloma

    Cellular immunotherapies can offer periods when people do not require treatment.

    by Christina Bennett

  • Forward Look

    Going Flat

    Most people who opt out of breast reconstruction are satisfied with their decision but are not always supported by their surgeons.

    by Kris Conner

  • Forward Look

    The Impact of HPV Vaccination

    Over a decade after human papillomavirus vaccines first became available in the U.S., their effect on cervical cancer incidence is becoming apparent.

    by Carisa D. Brewster

  • Forward Look

    What’s Next? Summer 2021

    Using fecal transplants to improve immunotherapy response

    by Natalie Slivinski